The Science of SMC1A: Genetics and Biology

At the core of a Developmental and Epileptic Encephalopathy 85 (DEE85) diagnosis is a change in the SMC1A gene. This gene is located on the X chromosome, one of the two chromosomes that determine biological sex ^[1]. Understanding why this gene is so critical to your child’s brain development requires looking at how it helps organize the very structure of life: your child’s DNA.

The Role of the Cohesin Complex

The SMC1A gene provides the blueprint for a protein that acts like a structural “ring” or “handcuff” around DNA ^[2]. This protein is a central part of the cohesin complex, a group of proteins that work together to:

• Organize DNA Loops: Cohesin helps fold long strands of DNA into organized loops, which allows different parts of the genome to communicate ^[3].
• Regulate Gene “Volume”: By bringing certain genes closer to their “on” switches, cohesin helps control how much protein a cell makes ^[4].
• Repair DNA: It helps stabilize DNA when it is damaged, ensuring the brain’s cells remain healthy ^[5].

When the SMC1A protein is missing or broken, the brain cannot properly regulate the “networks” of genes needed for typical development, leading to the seizures and developmental delays seen in DEE85 ^[6][7].

Why DEE85 Predominantly Affects Females

You may have noticed that almost everyone diagnosed with DEE85 is female. This is tied to how the X chromosome works.

• Females (XX): Have two X chromosomes. If one SMC1A gene is mutated, the second X chromosome provides some function, though they will experience the symptoms of DEE85 ^[8].
• Males (XY): Have only one X chromosome. Severe loss-of-function variants in SMC1A are often presumed lethal in males during early development ^[8][1]. However, male survival and presentation are possible, especially with hypomorphic, mosaic, or less severe variants.

Loss-of-Function vs. Dominant-Negative

Geneticists often distinguish DEE85 from Cornelia de Lange Syndrome (CdLS) based on the type of damage to the gene:

• DEE85 (often Loss-of-Function): These variants (often called nonsense or frameshift mutations) prevent the protein from being made ^[8][1]. This causes a severe dosage problem in the brain, leading to early, drug-resistant seizures ^[8].
• CdLS (often Dominant-Negative): These variants (often missense mutations) create a “broken” protein that gets in the way of healthy proteins. This leads to the physical features of CdLS but typically causes less severe epilepsy ^[8][9].

These relationships overlap; missense and other variants can have variable functional effects. The exact variant rarely provides a reliable individual forecast.

Why Every Child is Different

Even children with the exact same mutation can have different symptoms. This variability may be influenced by:

1. X-Chromosome Inactivation (XCI): In females, one X chromosome is turned off. However, SMC1A is generally an X-inactivation-escape gene, making this process complex. Furthermore, XCI measured in blood may not reflect expression in the brain. An XCI study is not a routine, reliable prognostic test ^[8][7].
2. Somatic Mosaicism: Sometimes, the mutation happens slightly later in development, meaning only some of the child’s cells have the mutation ^[7]. While mosaicism can affect severity, it varies by tissue and its clinical effect is not uniformly mild ^[10].

Genetic Counseling

Because SMC1A is complex, parents should consult a genetic counselor to discuss parent testing, potential parental mosaicism, and recurrence risk for future pregnancies.